from 2004 suggests that under continuous 24-hour evaluation, GHRP-2 may also increase growth hormone production from approximately 2030 gL24 h in placebo controls to about 120180 gL24 h with GHRP-2, suggesting an estimated 4- to 6-fold increase
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist, the next breakthrough
Either way, I am not complaining
En cualquier caso y, como siempre, lo ideal es recurrir al asesoramiento especializado antes de ponerse a tomarla motu proprio porque, aunque no tenga efectos secundarios significativos (si acaso, algn trastorno gastrointestinal leve), lo mejor es asesorarse siempre adecuadamente y que seamos pautados por un especialista